Henry C. Settle
Keine laufenden Positionen mehr
Profil
Mr. Henry C.
Settle, Jr. MBA, is Independent Director at KineMed, Inc. He is on the Board of Directors at KineMed, Inc.
Mr. Settle was previously employed as Chief Financial Officer by Emiliem, Inc., Chief Financial Officer by SuperGen, Inc., Partner-Life Sciences Practice by Ernst & Young LLP, a Principal by Affymetrix, Inc., a Principal by eConvergent, Inc., and a Principal by Theravance, Inc.
He received his undergraduate degree from the University of California, Santa Barbara and an MBA from the University of California, Los Angeles.
Ehemalige bekannte Positionen von Henry C. Settle
| Unternehmen | Position | Ende |
|---|---|---|
| KINEMED INC | Direktor/Vorstandsmitglied | - |
| KINEMED INC | Finanzdirektor/CFO | 01.01.2005 |
| KINEMED INC | Direktor/Vorstandsmitglied | - |
| INNOVIVA, INC. | Corporate Officer/Principal | - |
Ausbildung von Henry C. Settle
| University of California, Los Angeles | Masters Business Admin |
| University of California, Santa Barbara | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
SuperGen, Inc.
 SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | Health Technology |
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
KineMed, Inc.
 KineMed, Inc. Miscellaneous Commercial ServicesCommercial Services KineMed, Inc. develops and commercializes biomarker platform technology. It provides dynamic proteomics platform, a functionally interpretable systems biology platform. The company was founded by David M. Fineman and Marc K. Hellerstein in February 2001 and is headquartered in Emeryville, CA. | Commercial Services |